Full Agenda (subject to change)

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Emanuela M. Ghia, PhD – UC San Diego

Co-Chair: Marek Mraz, MD, PhD – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University

Co-Chair: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London

Co-Chair: Philip Thompson, MB, BS (Hons) – Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Erin M. Parry, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Moritz Fürstenau, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

Co-Chair: Elżbieta Iskierka-Jażdżewska, MD – Medical University of Lodz, Copernicus Memorial Hospital, Department of Hematology; Copernicus Memorial Hospital in Lodz, Medical University of Lodz, Department of General Hematology and Internal Medicine

Co-Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Marek Mraz, MD, PhD – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University